For Immediate Release:
October 24, 2012
Southcoast Health System updates patients on New England Compounding Center recall
NEW BEDFORD, Mass. — Southcoast™ Health System would like to proactively assure our patients that we have not purchased any steroid medications from the New England Compounding Center (NECC) — the medications found to have caused an outbreak of fungal meningitis throughout the country.
Southcoast had purchased other products from NECC and has discontinued the use of these products as both a precaution and per the advisement of the U.S. Centers for Disease Control & Prevention (CDC), U.S. Food & Drug Administration (FDA) and the Massachusetts Department of Public Health (DPH).
The products purchased include intrathecal injections, cardioplegic solution and vancomycin injections. An intrathecal injection is a medication administered for pain management, cardioplegic solution is used during open heart surgery and the vancomycin injections are used in cataract surgery. Again, none of these medications are the steroid medication found to have caused an outbreak of fungal meningitis and Southcoast has identified alternative sources for the medications previously purchased.
Southcoast is taking this recommendation very seriously and, out of an abundance of caution as recommended by the FDA, is reaching out to all patients who received an intrathecal injection, cardioplegic solution or a vancomycin injection that was compounded by NECC since May 21, 2012. Patients who have questions should contact their health care providers.
If patients who have received any of the medications have any of the following symptoms, they should seek medical care: fever, headache, stiff neck, nausea and vomiting, sensitivity to light, dizziness, and confusion. CDC is not recommending any treatment for patients who have been exposed to NECC produced medications and have no symptoms of illness at this time. More information is available at the following CDC website: http://www.cdc.gov/HAI/menigitis.html.
Southcoast will provide updates as information becomes available from health officials.






